Danaher Corporation

NYSE:DHR Stock Report

Market Cap: US$165.1b

Danaher Past Earnings Performance

Past criteria checks 2/6

Danaher has been growing earnings at an average annual rate of 9.3%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 5.1% per year. Danaher's return on equity is 7.7%, and it has net margins of 16.6%.

Key information

9.3%

Earnings growth rate

8.6%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate5.1%
Return on equity7.7%
Net Margin16.6%
Last Earnings Update27 Sep 2024

Recent past performance updates

Recent updates

Danaher: A Resilient And Solid Company With Growth Potential

Dec 10

Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly

Dec 08
Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly

Understanding Danaher's Cautiousness

Oct 25

Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Sep 28
Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Danaher Q3 Preview: Market Share Gains In Molecular Testing

Sep 25

Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Sep 12
Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Aug 28
Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Danaher: Lofty Price, Bright Future

Aug 22

Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Aug 13
Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Danaher: Valuation Now Too High Even Compared To Own High Standards

Jul 16

What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Jun 23
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Jun 20

Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Jun 05
Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Is Danaher (NYSE:DHR) A Risky Investment?

May 21
Is Danaher (NYSE:DHR) A Risky Investment?

It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

May 01
It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

Value Vs. Growth? Danaher Says Why Not Both?

Apr 25

Danaher: All In On Life Sciences, And Market Update

Mar 27

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Mar 11
Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Is Danaher (NYSE:DHR) Using Too Much Debt?

Jan 12
Is Danaher (NYSE:DHR) Using Too Much Debt?

My Top 2024 Stock Pick: Danaher

Dec 27

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Nov 26

RGA Investment Advisors - Danaher:  Purity In The Crown Jewel Of Bioprocessing

Nov 19

Why Danaher Is One Of My Favorite Long-Term Investments

Oct 26

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Oct 17

Should Danaher Investors Sell New Veralto Shares?

Oct 02

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

Revenue & Expenses Breakdown

How Danaher makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:DHR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
27 Sep 2423,7423,9347,4701,549
28 Jun 2423,5684,0567,3581,528
29 Mar 2423,7374,0697,2811,498
31 Dec 2323,8904,2007,2451,503
29 Sep 2321,0264,4086,0801,332
30 Jun 2323,0655,0196,4891,390
31 Mar 2324,9045,7576,7621,460
31 Dec 2226,6436,2227,0801,528
30 Sep 2231,2506,6408,5721,787
01 Jul 2230,8166,2068,4891,808
01 Apr 2230,2836,2068,3691,803
31 Dec 2124,8025,2836,7631,498
01 Oct 2128,0655,6367,8181,643
02 Jul 2126,7205,3617,5431,544
02 Apr 2124,7994,5957,2781,441
31 Dec 2022,2843,5106,8801,348
02 Oct 2020,3923,0836,3541,246
03 Jul 2018,8862,8535,9541,186
03 Apr 2018,0342,6145,6591,146
31 Dec 1917,9112,3645,5771,126
27 Sep 1915,5622,0934,709980
28 Jun 1916,0372,1454,880998
29 Mar 1916,5732,1665,1251,028
31 Dec 1817,0492,4065,3561,059
28 Sep 1819,6152,7616,2461,211
29 Jun 1819,2902,6696,1731,189
30 Mar 1818,8192,5536,0721,160
31 Dec 1715,5192,1725,012956
29 Sep 1717,8282,3605,7641,098
30 Jun 1717,4322,1915,6331,060
31 Mar 1717,1642,0515,5361,016
31 Dec 1616,8822,1535,481975
30 Sep 1616,6211,9275,362943
01 Jul 1616,0011,9055,218914
01 Apr 1613,6631,7754,549788
31 Dec 1514,4341,7474,635861
02 Oct 1515,3351,8754,769926
03 Jul 1516,5302,1774,8651,002
03 Apr 1519,1862,5215,3481,143
31 Dec 1412,8671,6393,953769
26 Sep 1419,1972,6835,3051,189
27 Jun 1419,1592,5995,3111,210
28 Mar 1419,3362,5835,4051,267
31 Dec 1318,2832,5915,0421,104

Quality Earnings: DHR has high quality earnings.

Growing Profit Margin: DHR's current net profit margins (16.6%) are lower than last year (21%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DHR's earnings have grown by 9.3% per year over the past 5 years.

Accelerating Growth: DHR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DHR had negative earnings growth (-11%) over the past year, making it difficult to compare to the Life Sciences industry average (-4.7%).

Return on Equity

High ROE: DHR's Return on Equity (7.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/27
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Danaher Corporation is covered by 54 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John EadeArgus Research Company
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research